In the face of such pressure, pharmaceutical companies are eager to reduce the cost of drug development ... costly inefficiencies in the drug discovery and development process.

Researchers estimated a median direct research and development cost of $150 million compared to a mean of $369 million. Costs were higher after adjusting for earnings drug developers could have ...

Drug discovery is a costly and time-intensive process, with binding free energy calculations between the potential drug ...

Launch of Hyde Park Discovery between UChicago, Deerfield Management to accelerate research into life-saving treatments ...

A high drug failure rate is more than just a pattern recognition problem. Here's how we can address some of the root causes.

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

Success hinges on the industry applying impactful solutions across drug discovery, development and commercialization to reduce costs and speed up processes. It’s estimated that GenAI alone could ...

The global drug discovery services market is set for remarkable growth, with its valuation projected to surge from USD 19.7 ...

Visakhapatnam: Drug repurposing is emerging as a promising strategy for tackling drug-resistant and metastatic cancers.

The pharmaceutical industry is on the verge of a significant transformation due to the emergence of artificial intelligence ...

drug discovery and development activities with its partners or potential partners, Absci’s dependence on third parties to support its internal development programs, including for the manufacture ...